This protocol addresses the granulomatous subtype of rosacea — also known as lupoid rosacea — which presents with reddish-brown papules or nodules occurring alongside diffuse facial erythema and is confirmed histologically.
Reddish-brown papules or nodules presenting concomitantly with diffuse facial erythema are the hallmark sign for granulomatous rosacea. In this subtype, histological examination reveals non-caseating epithelioid cell granulomas, distinguishing it from other rosacea presentations.
Management of granulomatous rosacea draws on both systemic and procedural options, alongside topical agents that have demonstrated effectiveness in this presentation.
Reddish-brown papules or nodules presenting concomitantly with diffuse facial erythema are the hallmark sign for granulomatous rosacea also known as lupoid rosacea.
In the granulomatous subtype of rosacea, non-caseating epithelioid cell granulomas arise.
Minocycline, dapsone, isotretinoin and intense pulsed light (IPL) have been published as successful treatments.
Topical treatments with pimecrolimus cream and azelaic acid gel were successful.
In practice, treatment that has qualified for papulopustular rosacea can be used for GR.
View source ↗